1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Retinal Neovascularization in 1 studies
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.
Retinal Neovascularization: Formation of new blood vessels originating from the retinal veins and extending along the inner (vitreal) surface of the retina.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kroll, J | 1 |
| Epting, D | 1 |
| Kern, K | 1 |
| Dietz, CT | 1 |
| Feng, Y | 1 |
| Hammes, HP | 1 |
| Wieland, T | 1 |
| Augustin, HG | 1 |
1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Retinal Neovascularization
| Article | Year |
|---|---|
Inhibition of Rho-dependent kinases ROCK I/II activates VEGF-driven retinal neovascularization and sprouting angiogenesis.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiogenesis Inducing Agents; Angiogenesis Inhibitors | 2009 |